Assignee
AAVNERGENE INC
US·2 granted patents·2 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
4 records- 0169US12583907B2Modified plasma clotting factor VIII and method of use thereofAAVNERGENE INC·Filed 2023·Granted Mar 24, 2026·0 cites·17 claims
- 0258US2024229067A9Compositions and methods for recombinant parvovirus productionAAVNERGENE INC·Filed 2023·Application pending·0 cites
- 0356US2023365991A1Compositions and methods for recombinant parvovirus productionAAVNERGENE INC·Filed 2023·Application pending·0 cites
- 0455US11795207B2Modified plasma clotting factor VIII and method of use thereofAAVNERGENE INC·Filed 2021·Granted Oct 24, 2023·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when AAVNERGENE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →